| Product Name | Multi-Tumor Marker 7-Item Assay Reagent, Fluorescence Flow Cytometry |
| Catalog No. | TMTR-HMM-0034 |
| Description | Auxiliary diagnosis of lung cancer: Among the 7 combined tests, CYFRA21-1, NSE, CEA and CA125 are combined tests for lung cancer, which can enhance the auxiliary diagnostic value for lung cancer. Auxiliary diagnosis of liver cancer: In the 7-test combination, AFP is a specific indicator for liver cancer, CEA differentiates primary and secondary liver cancer, and free- β -HCG differentiates primary liver cancer from reproductive tumors. Digestive system tumors: In the 7-test combination, CEA and CA242 can be used as prognosis assessment and postoperative tumor markers for gastric cancer, while free-β -HCG is mainly used for prognosis assessment. |
| Application | This product is used for dynamic monitoring of patients with malignant tumors to assist in judging the disease progression or treatment effect. |
| Test Item | AFP, CA125, Cyfra21-1, CA24-2, CEA, free-β-hCG, NSE |
| Specimen Type | Serum |
| Sample Capacity | 20 µL |
| Applicable Instruments | Multifunctional flow dot matrix analyzer, fully automatic flow fluorescence luminescence immunoanalyzer |
| Detection Method | Fluorescence Flow Cytometry |
| Storage | 2-8°C |
| Shelf Life | 12 months |
For research use only, not for clinical use.
|
There is no product in your cart. |
Copyright © 2025 Alta DiagenoTech. All rights reserved.
